Minimally-invasive procedure provides high-risk patients with advanced option for treatment of aortic stenosis

NYU Langone Medical Center became the first academic medical centre to implant a newly FDA-approved heart valve for transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis. Mathew R. Williams, MD performed the TAVR procedure and the patient was discharged to her home only two days later. Five additional patients have successfully undergone the procedure since then.